IP Library › Granted Patent US 12,509,486
Granted Patent B2
US 12,509,486 · App. 18/228,604 · Granted Dec 30, 2025

DNA gridiron compositions and methods

Inventors: Dongran Han (Cambridge, MA); Hao Yan (Chandler, AZ)
Assignee: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
C07H21/04C07H1/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,509,486
App. No.
18/228,604
Granted
Dec 30, 2025
Kind
B2
Abstract

Novel compositions and methods for engineering wireframe architectures and scaffolds of increasing complexity by creating gridiron-like DNA structures (FIG. 1 ). A series of four-arm junctions are used as vertices within a network of double-helical DNA fragments. Deliberate distortion of the junctions from their most relaxed conformations ensures that a scaffold strand can traverse through individual vertices in multiple directions. DNA gridirons, ranging from two-dimensional arrays with reconfigurability to multilayer and three-dimensional structures and curved objects, can be assembled according the methods presented herein.

Claims (20)

1 . A method of forming a DNA gridiron unit, comprising:

combining a plurality of scaffold strands and staple strands complementary to said scaffold strand under conditions suitable for the formation of four four-arm junctions linked together in a two-layer square frame in which helices on opposite sides lie in the same plane.

2 . The method of claim 1 , wherein said scaffold strands comprise single stranded M13mp18 DNA.

3 . The method of claim 1 , wherein said scaffold strands are combined with a 10-x molar excess of staple strands in TAE Mg 2+ buffer.

4 . The method of claim 1 , wherein said scaffold strands and staple strands are annealed at 95 to 86° C. at 4° C. per 5 min; 85 to 70° C. at 1° C. per 5 min; 70 to 40° C. at 1° C. per 15 min; then 40 to 25° C. at 1° C. per 10 min.

5 . The method of claim 4 , wherein said scaffold strands and staple strands are annealed at 95 to 76° C. at 2° C. per 5 minutes; then 76 to 24° C. at 4° C. per 5 minutes.

6 . A method of forming a DNA origami nanostructure, comprising:

linking a plurality of DNA gridiron units of a selected sequence of nucleotides under conditions suitable to form a 2D or 3D lattice of a selected shape.

7 . The method of claim 6 , wherein the selected shape is a S-shape, sphere, or screw.

8 . A DNA nanostructure comprising

a plurality of immobile Holliday junction analogs linked together in a plurality of layered frames, wherein each layer of frame has at least two DNA helices which lie on opposite sides of the Holliday junction which also lie in the same plane, and wherein said plurality of immobile Holliday junction analogs are linked together with a central strand of single-stranded DNA within said layer of frame,

and

wherein one or more of the plurality of immobile Holliday junction analogs together form a curvilinear surface.

9 . The DNA nanostructure of claim 8 , wherein a layer of frame is distorted along the plane of the layer.

10 . The DNA nanostructure of claim 8 , wherein the DNA nanostructure is in the shape of a sphere, S-shaped structure, or screw.

11 . The DNA nanostructure of claim 10 , wherein the DNA nanostructure is in the shape of a sphere.

12 . The DNA nanostructure of claim 11 , wherein the sphere confines an interstitial space defining a cavity.

13 . The DNA nanostructure of claim 8 , wherein said single stranded DNA comprises M13mp18 DNA.

14 . The DNA nanostructure of claim 13 , further comprising one or a plurality of staple strand sequences.

15 . The DNA nanostructure of claim 14 , wherein the staple strand sequences are independently from 40 to 45 nucleotides in length.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 31, 2023
From: HAN, DONGRAN; YAN, HAO
To: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
Reel/Frame 064442/0229 →
Continuity (5)
Continuation 16938474 · Jul 24, 2020
Continuation 16202841 · Nov 28, 2018
Continuation 15121007
Provisional Application 61944677 · Feb 26, 2014
Related Publication 20240150392A1 · May 9, 2024
References Cited (88)
US 4469863A · Ts'o et al. · 1984 [cited by applicant]
US 4559157A · Smith et al. · 1985 [cited by applicant]
US 4608392A · Jacquet et al. · 1986 [cited by applicant]
US 4612302A · Szabo et al. · 1986 [cited by applicant]
US 4684620A · Hruby et al. · 1987 [cited by applicant]
US 4816567A · Cabilly et al. · 1989 [cited by applicant]
US 4820508A · Wortzman · 1989 [cited by applicant]
US 4853371A · Coy et al. · 1989 [cited by applicant]
US 4873192A · Kunkel · 1989 [cited by applicant]
US 4938949A · Borch et al. · 1990 [cited by applicant]
US 4992478A · Geria · 1991 [cited by applicant]
US 5023243A · Tullis · 1991 [cited by applicant]
US 6239116B1 · Krieg et al. · 2001 [cited by applicant]
US 10189874B2 · Han · 2019 [cited by examiner]
US 10774107B2 · Han · 2020 [cited by examiner]
US 11760774B2 · Han · 2023 [cited by examiner]
US 20070082352A1 · Cumpson · 2007 [cited by applicant]
US 20080124366A1 · Ohlfest et al. · 2008 [cited by applicant]
US 20110275702A1 · Chang et al. · 2011 [cited by applicant]
US 20120190732A1 · Chang et al. · 2012 [cited by applicant]
US 20150004193A1 · Chang et al. · 2015 [cited by applicant]
WO WO2010060030A1 · 2010 [cited by applicant]
WO WO2013119676A1 · 2013 [cited by applicant]
Agrawal et al., (1988). “Oligodeoxynucleoside phophoramidates and phosphorrothioates as inhibitors of human immunodeficiency virus.” Proc. Natl. Acad. Sci. 85: 7079-7083. [cited by applicant]
Agrawal et al., (1992). “Antisense oligonucleotides as antiviral agents.” Trends in Biotechnology 10: 152-158. [cited by applicant]
Bachmann et al., (2010). “Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns.” Natural Reviews Immunology 10:787-796. [cited by applicant]
Ballas et al., (1996). “Induction of NK Activity in Murine and Human Cells by CpG Motifs in Oligodeoxynucleotides and Bacterial DNA.” J. Immunol. 157(5): 1840-1845. [cited by applicant]
Beaucage et al., (1981). “Deoxynucleoside Phosphoramidites—A New Class of Key Intermediates for Deoxypolynucleotide Synthesis.” Tetrahedron Letters 22(20): 1859-1862. [cited by applicant]
Bode et al., (2011). “CpG DNA as a vaccine adjuvant.” Expert Rev. Vaccines 10(4 ): 499-511. [cited by applicant]
Burton, (2010). “Scaffolding to build a rational vaccine design strategy.” PNAS 107(42): 17859-17860. [cited by applicant]
Cao and Chen, “Characterization of Antibody Responses Against the 2F5 Epitope ELDKWA Using HIV-1 Env-Mediated Membrane Fusion and Neutralization Assays.” Tsinghua Science and Technology, 2010; 15(4): 447-451. [cited by applicant]
Clackson et al., (1991). “Making antibody fragments using phage display libraries.” Nature 352: 624-628. [cited by applicant]
Cowdrey et al., (1996). “Bacterial DNA Induces NK Cells to Produce IFN-gamma In Vivo and Increases the Toxicity of Lipopolysaccharides.” The Journal of Immunology 156(12): 4570-4575. [cited by applicant]
Dayhoff et al., (1978). “A Model of Evolutionary Change in Proteins.” Atlas of Protein Sequence and Structure 345-352. [cited by applicant]
Dietz H. et al., “Folding DNA into Twisted and Curved Nanoscale Shapes”, Science 325(5941), 725-730 (2009). [cited by applicant]
Douglas S. et al., “Self-assembly of DNA into nanoscale three-dimensional shapes”, Nature 459, 414-418 (2009). [cited by applicant]
Elgueta et al., (2010). The immortality of humeral immunity. Immunological Reviews 236: 139-150. [cited by applicant]
Froehler et al., (1986). “Deoxyncleoside H-Phosphonate diester intermediates in the synthesis of internucleotide phosphate analogues.” Tetrahedron Letters 27(46): 5575-5578. [cited by applicant]
Froehler et al., (1986). “Synthesis of DNA via deoxynucleoside H-phosphonate intermediates.” Nucleic Acids Research 14( 13 ): 5399-5407. [cited by applicant]
Fu T. et al., “DNA Double-Crossover Molecules”, Biochemistry 32(13), 3211-3220 (1993). [cited by applicant]
Gaffney et al., (1988). “Large-scale oligonucleotide synthesis by the H-phosphonate method.” Tetrahedron Letters 29(22): 2619-2622. [cited by applicant]
Garegg et al., (1986). “Nucleoside H-Phosphonates. Ill. Chemical synthesis of oligodeoxyribonucleotides by the hydrogenphophonate approach.” Tetrahedron Letters 27(34): 4051-4054. [cited by applicant]
Garegg et al., (1986). “Nucleoside H-phosphonates. IV. Automated solid phase synthesis of oligoribonucleotides by the hydrogenphosphonate approach.” Tetrahedron Letters 27(34): 4055-4058. [cited by applicant]
Gietl A. et al., “DNA origami as biocompatible surface to match single-molecule and ensemble experiments”, Nucleic Acids Res 40(14), e110 (2012), 10 pages. [cited by applicant]
Goodchild (1990). “Conjugates of oligonucleotides and modified oligonucleotides: a review of their synthesis and properties.” Bioconjugate Chemistry 1 (3): 165-187. [cited by applicant]
Han D. et al., “DNA gridiron nanostructures based on four-arm junctions”, Science 339(6126), 1412-1415 (2013). [cited by applicant]
Han et al., (2011). “DNA Origami with Complex Curvatures in Three-Dimensional Space.” Science 332(6027): 342-346. [cited by applicant]
He et al., (2008). “Hierarchical self-assembly of DNA into symmetric supramolecular polyhedral.” Nature 452: 198-202. [cited by applicant]
Hosmalin et al. Priming With T Helper Cell Epitope Peptides Enhances the Antibody Response to the Envelope Glycoprotein of HIV-1 In Primates. J. Immunol. 1991; 146(5): 1667-1673. [cited by applicant]
Jerala M. et al., “A DNA Origami of Slovenia in Nano Dimensions”, Acta Chim Slav 58(1), 181-184 (2011). [cited by applicant]
Ke et al., (2008). “Self-Assembled Water-Soluble Nucleic Acid Probe Tiles for Label-Free RNA Hybridization Assays.” Science 319: 180-183. [cited by applicant]
Kohler et al., (1975). “Continuous cultures of fused cells secreting antibody of predefined specificity.” Nature 256:495-497. [cited by applicant]
Krieg et al., (1995). “CpG motifs in bacterial DNA trigger direct B-cell activation.” Nature 374(6522): 546-549. [cited by applicant]
Kunkel et al., (1987). “Rapid and efficient site-specific mutagenesis without phenotypic selection.” Methods in Enzymology 154: 367-382. [cited by applicant]
Kunkel, (1985). “Rapid and efficient site-specific mutagenesis without phenotypic selection.” Proc. Natl. Acad. Sci. 82: 488-492. [cited by applicant]
Kutsch et al., (2002). “Direct and Quantitative Single-Cell Analysis of Human Immunodeficiency Virus Type 1 Reactivation from Latency.” J Viral. 76(17): 8776-8786. [cited by applicant]
Li et al., (2011). “Self-Assembled Multivalent DNA Nanostructures for Noninvasive Intracellular Delivery of Immunostimulator CpG Oligonucleotides.” ACS Nano 5(11 ): 8783-8789. [cited by applicant]
Liu et al., (2011). “Targeted Cell-Cell Interactions by DNA Nanoscaffold-Templated Multivalent Bispecific Aptamers.” Small 7(12): 1673-1682. [cited by applicant]
Liu et al., (2012). “A DNA Nanostructure Platform for Directed Assembly of Synthetic Vaccines.” Nano Letters 12: 4254-4259. [cited by applicant]
Lu et al., (2010). “Polyvalent AIDS Vaccines.” Current HIV Research 8(8): 622-629. [cited by applicant]
Mao C. et al., “Designed Two-Dimensional DNA Holliday Junction Arrays Visualized by Atomic Force Microscopy”, J I\m Chem Soc 121(23), 5437-5443 (1999). [cited by applicant]
Marini M. et al., “A Revertible, Autonomous, Self-Assembled DNA-Origami Nanoactuator”, Nano Lett 11(12), 5449-5454 (2011). [cited by applicant]
Marks et al., (1991). “By-passing immunization: Human antibodies from V-gene libraries displayed on phage.” Journal of Molecular Biology 222(3): 581-597. [cited by applicant]
Marks et al., (1992). “By-Passing Immunization: Building High Affinity Human Antibodies by Chain Shuffling.” Bio/ Technology 10: 779-783. [cited by applicant]
Mccafferty et al., (1990). “Phage antibodies: filamentous phage displaying antibody variable domains.” Nature 348: 552-554. [cited by applicant]
Mcelrath et al., (2010) “Induction of Immunity to Human Immunodeficiency Virus Type-1 by Vaccination.” Immunity 33(4): 542-554. [cited by applicant]
Mcghee et al., (1993). “New Perspectives in Mucosal Immunity With Emphasis On Vaccine Development,” Sem. Hematol., 30(4): 3-15. [cited by applicant]
Mckinney S. et al., “Structural dynamics of individual Holliday junctions”, Nature Struct Biol 10(2), 93-97 (2002). [cited by applicant]
Miick S. et al., “Crossover isomer bias is the primary sequence-dependent property of immobilized Holliday junctions” Proc Nall Acad Sci USA 94(17), 9080-9084 (1997). [cited by applicant]
Morrison et al., (1984). “Chimeric human antibody molecules: Mouse antigen-binding domains with human constant region domains.” Proc. Natl. Acad. Sci. 81: 6851-6855. [cited by applicant]
Moses et al., (2007). “The growing applications of click chemistry.” Chem. Soc. Rev. 2007 36(8): 1249-62. [cited by applicant]
Mouquet et al., (2010). “Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation.” Nature 467: 591-596. [cited by applicant]
Ofek et al., (2010). “Elicitation of Structure-Specific Antibodies by Epitope Scaffolds.” PNAS 107(42): 17880-17887. [cited by applicant]
Patent Cooperation Treaty, International Search Authority, Search Report and Written Opinion for PCT/US15/17553, 16 pages, Jun. 17, 2015. [cited by applicant]
Patent Cooperation Treaty, International Searching Authority, Search Report and Written Opinion for PCT/ US2013/24945, 9 pages, May 20, 2013. [cited by applicant]
Roberts et al., (2011). “B cells do not take up bacterial DNA: an essential role for antigen in exposure of DNA to toll-like receptor-9.” Immunology & Cell Biology 89(4): 517-525. [cited by applicant]
Rostovtsev et al., (2002). “A Stepwise Huisgen Cycloaddition Process: Copper (1)-Catalyzed Regioselective ‘Ligation’ of Azides and Terminal Alkynes.” Angew. Chem. Int. Ed. 41(14): 2596-2599. [cited by applicant]
Rothemund W., “Folding DNA to create nanoscale shapes and patterns”, Nature 440, 297-302 (2006). [cited by applicant]
Seeman N., “Nanomaterials Based on DNA”, Annu Rev Biochem 79, 65-87 (2010). [cited by applicant]
Seeman, (2003). “At the Crossroads of Chemistry, Biology, and Materials: Structural DNA Nanotechnology.” Chemistry & Biology 10: 1151-1159. [cited by applicant]
Uhlmann et al., (1990). “Antisense Oligonucleotides: A New Therapeutic Principle.” Chemical Reviews 90(4). [cited by applicant]
Van Duyne et al., (2009). “The utilization of humanized mouse models for the study of human retroviral infections.” Retrovirology 6: 76. [cited by applicant]
Waterhouse et al., (1993). “Combinatorial infection and in vivo recombination: a strategy for making large phage antibody repertoires.” Nucleic Acids Research 21 (9): 2265-2266. [cited by applicant]
Zhang et al., (2010). “Exterior Modification of a DNA Tetrahedron.” Chem Commun. 46: 6792-6794. [cited by applicant]
Zhao et al., (2010). “A Route to Scale up DNA Origami using DNA Tiles as Folding Staples.” Angew. Chem. Int. Ed. 49: 1414-1417. [cited by applicant]
Zhao Z et al., “Organizing DNA Origami Tiles Into Larger Structures Using Preformed Scaffold Frames”, Nano Lett 11 (7), 2997-3002 (2011). [cited by applicant]
Zolla-Pazner “Identifying Epitopes of HIV-1 That Induce Protective Antibodies”. Nat. Rev. Immunol. 2004; 4:199-210. [cited by applicant]
Zolnik et al. “Minireview: Nanoparticles and the Immune System.” Endocrinol. 2010; 151 (2): 458-465. [cited by applicant]